Corient Private Wealth LLC lessened its stake in Amdocs Limited (NASDAQ:DOX - Free Report) by 5.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 72,328 shares of the technology company's stock after selling 4,021 shares during the period. Corient Private Wealth LLC owned 0.06% of Amdocs worth $6,158,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of DOX. First Horizon Advisors Inc. grew its position in shares of Amdocs by 1.9% during the 3rd quarter. First Horizon Advisors Inc. now owns 5,902 shares of the technology company's stock worth $516,000 after buying an additional 109 shares during the period. Private Trust Co. NA boosted its stake in Amdocs by 62.9% in the third quarter. Private Trust Co. NA now owns 303 shares of the technology company's stock valued at $27,000 after acquiring an additional 117 shares during the last quarter. Principal Securities Inc. raised its position in shares of Amdocs by 10.4% during the 4th quarter. Principal Securities Inc. now owns 1,341 shares of the technology company's stock valued at $114,000 after acquiring an additional 126 shares during the last quarter. Morton Community Bank raised its position in shares of Amdocs by 0.4% during the 3rd quarter. Morton Community Bank now owns 36,410 shares of the technology company's stock valued at $3,185,000 after acquiring an additional 130 shares during the last quarter. Finally, Global Retirement Partners LLC lifted its stake in shares of Amdocs by 45.6% in the 4th quarter. Global Retirement Partners LLC now owns 559 shares of the technology company's stock valued at $48,000 after purchasing an additional 175 shares during the period. Institutional investors and hedge funds own 92.02% of the company's stock.
Amdocs Stock Up 1.7 %
Shares of NASDAQ DOX traded up $1.55 during mid-day trading on Wednesday, reaching $91.97. 730,214 shares of the company's stock were exchanged, compared to its average volume of 657,074. The company has a current ratio of 1.16, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22. The business has a fifty day simple moving average of $87.46 and a 200 day simple moving average of $87.23. Amdocs Limited has a twelve month low of $74.41 and a twelve month high of $93.34. The firm has a market capitalization of $10.38 billion, a price-to-earnings ratio of 21.34, a PEG ratio of 1.47 and a beta of 0.68.
Amdocs (NASDAQ:DOX - Get Free Report) last announced its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share for the quarter, missing analysts' consensus estimates of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. As a group, equities analysts expect that Amdocs Limited will post 6.21 EPS for the current fiscal year.
Amdocs Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Monday, March 31st will be paid a $0.527 dividend. This is an increase from Amdocs's previous quarterly dividend of $0.48. The ex-dividend date is Monday, March 31st. This represents a $2.11 annualized dividend and a dividend yield of 2.29%. Amdocs's dividend payout ratio (DPR) is currently 48.72%.
Analysts Set New Price Targets
Separately, StockNews.com lowered Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 28th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $101.20.
View Our Latest Stock Analysis on DOX
Amdocs Company Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.